Daphne Karydas

Daphne Karydas

Directeur/Bestuurslid bij MINERALYS THERAPEUTICS, INC.

Vermogen: 112 716 $ op 31-10-2026

53 jaar
Health Technology
Finance
Consumer Services

Profiel

Ms. Daphne Karydas is a President & Chief Financial Officer at Serapha Bio, Inc., an Independent Director at Compass Pathways Plc and an Independent Director at Mineralys Therapeutics, Inc. She is on the Board of Directors at Compass Pathways Plc, Mineralys Therapeutics, Inc. and Epikast, Inc. Ms. Karydas was previously employed as a President & Chief Financial Officer by Flare Therapeutics, Inc., an Independent Director by LogicBio Therapeutics, Inc., a Chief Financial Officer by Syndax Pharmaceuticals, Inc., an Independent Director by Elicio Therapeutics, Inc. (United States), an Independent Director by Eucrates Biomedical Acquisition Corp., a Senior VP-Corporate Financial Planning & Analysis by Allergan Ltd. (Ireland), an Executive Director by JPMorgan Investment Management, Inc., a Vice President by BNY Mellon Investment Adviser, Inc., a Director & Senior Equity Analyst by The Boston Company Asset Management LLC, a Vice President by Goldman Sachs Asset Management LP, an Associate by Goldman Sachs & Co., and a Project Chemical Engineer by Merck & Co., Inc. She received her undergraduate degree from Massachusetts Institute of Technology, a graduate degree from Massachusetts Institute of Technology and an MBA from Harvard Business School.

Bekende belangen in openbare bedrijven

OndernemingDatumAantal aandelenTotale waardeWaarderingsdatum
15-09-2026 6.200 ( 0,01% ) 112 716 $ 31-10-2026
27-05-2026 0 ( -.--% ) - $ 31-10-2026

Actieve functies van Daphne Karydas

BedrijvenFunctieBegin
MINERALYS THERAPEUTICS, INC. Directeur/Bestuurslid 13-09-2023
COMPASS PATHWAYS PLC Directeur/Bestuurslid 18-09-2023
Directeur/Bestuurslid -

Eerdere bekende functies van Daphne Karydas

BedrijvenFunctieEinde
Financieel Directeur/CFO 08-09-2026
LOGICBIO THERAPEUTICS, INC. Directeur/Bestuurslid 16-11-2022
SYNDAX PHARMACEUTICALS, INC. Financieel Directeur/CFO 22-10-2021
ALLERGAN PLC Public Communications Contact 10-12-2018
Analyst-Equity 01-04-2017
Ervaring van Daphne Karydas in detail bekijken

Opleiding van Daphne Karydas

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

87

Eerstegraads connecties

17

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit17

Finance

Finance

Health Technology

Finance

Finance

Health Technology

Health Technology

Finance

Finance

Health Technology

Consumer Services

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Technology Services

  1. Beurs
  2. Insiders
  3. Daphne Karydas